(VIANEWS) – Alpine Global Premier Properties Fund Alpine Global Premier Properties Fund (AWP), Tekla Healthcare Opportunies Fund Shares of Beneficial Interest (THQ), The RMR Group (RMR) have the highest dividend yield stocks on this list.
| Financial Asset | Forward Dividend Yield | Updated (EST) |
|---|---|---|
| Alpine Global Premier Properties Fund Alpine Global Premier Properties Fund (AWP) | 12.73% | 2024-05-09 04:17:05 |
| Tekla Healthcare Opportunies Fund Shares of Beneficial Interest (THQ) | 8.43% | 2024-04-25 13:07:05 |
| The RMR Group (RMR) | 7.47% | 2024-05-07 10:43:06 |
| CHS (CHSCN) | 7.03% | 2024-04-27 07:14:05 |
| Sonic Automotive (SAH) | 2.35% | 2024-04-25 01:14:07 |
| Abbott Laboratories (ABT) | 2.08% | 2024-05-05 03:14:35 |
Almost 2K companies listed in the Nasdaq and NYSE pay out dividends to its shareholders. The dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.
1. Alpine Global Premier Properties Fund Alpine Global Premier Properties Fund (AWP) – Dividend Yield: 12.73%
Alpine Global Premier Properties Fund Alpine Global Premier Properties Fund’s last close was $3.77, 8.94% below its 52-week high of $4.14. Intraday change was -0.79%.
Alpine Global Premier Properties Fund is a closed-end equity mutual fund launched and managed by Alpine Woods Capital Investors, LLC. It invests in the public equity markets across the globe. The fund invests in stocks of companies operating across real estate sectors. It invests in value stocks of companies. The fund employs fundamental analysis with top-down and bottom-up stock picking approach to create its portfolio. It benchmarks the performance of its portfolio against the FTSE EPRA/NAREIT Global TR Index, MSCI US REIT Gross Total Return Index, and S&P Developed BMI Property Index Net TR Index. Alpine Global Premier Properties Fund was formed on February 13, 2007 and is domiciled in the United States.
Earnings Per Share
As for profitability, Alpine Global Premier Properties Fund Alpine Global Premier Properties Fund has a trailing twelve months EPS of $-0.18.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -4.67%.
Volume
Today’s last reported volume for Alpine Global Premier Properties Fund Alpine Global Premier Properties Fund is 126610 which is 51.7% below its average volume of 262163.
Dividend Yield
As maintained by Morningstar, Inc., the next dividend payment is on Apr 22, 2024, the estimated forward annual dividend rate is 0.48 and the estimated forward annual dividend yield is 12.73%.
More news about Alpine Global Premier Properties Fund Alpine Global Premier Properties Fund.
2. Tekla Healthcare Opportunies Fund Shares of Beneficial Interest (THQ) – Dividend Yield: 8.43%
Tekla Healthcare Opportunies Fund Shares of Beneficial Interest’s last close was $19.44, 4.61% under its 52-week high of $20.38. Intraday change was -0.82%.
Tekla Healthcare Opportunities Fund is a closed ended balanced mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity and fixed income markets across the globe. It seeks to invest in securities of companies operating in the healthcare sector. The fund also invests in pooled investment vehicles. For its fixed income portion, the fund invests in corporate debt securities across the credit rating spectrum. It benchmarks the performance of its portfolio against the S&P 1500 Healthcare Index and S&P 500 Index. Tekla Healthcare Opportunities Fund was formed on April 2, 2014 and is domiciled in the United States.
Earnings Per Share
As for profitability, Tekla Healthcare Opportunies Fund Shares of Beneficial Interest has a trailing twelve months EPS of $-1.48.
Moving Average
Tekla Healthcare Opportunies Fund Shares of Beneficial Interest’s value is below its 50-day moving average of $19.64 and above its 200-day moving average of $18.32.
Dividend Yield
As stated by Morningstar, Inc., the next dividend payment is on Oct 19, 2023, the estimated forward annual dividend rate is 1.35 and the estimated forward annual dividend yield is 8.43%.
More news about Tekla Healthcare Opportunies Fund Shares of Beneficial Interest.
3. The RMR Group (RMR) – Dividend Yield: 7.47%
The RMR Group’s last close was $24.11, 16.34% under its 52-week high of $28.82. Intraday change was 0.08%.
The RMR Group Inc., through its subsidiary, The RMR Group LLC, provides business and property management services in the United States. The company provides management services to its four publicly traded real estate investment trusts and three real estate operating companies. It also provides investment advisory services. The company was formerly known as REIT Management & Research Inc. and changed its name to The RMR Group Inc. in September 2015. The RMR Group Inc. was founded in 1986 and is headquartered in Newton, Massachusetts.
Earnings Per Share
As for profitability, The RMR Group has a trailing twelve months EPS of $3.48.
PE Ratio
The RMR Group has a trailing twelve months price to earnings ratio of 6.93. Meaning, the purchaser of the share is investing $6.93 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 32.51%.
Dividend Yield
As stated by Morningstar, Inc., the next dividend payment is on Apr 19, 2024, the estimated forward annual dividend rate is 1.8 and the estimated forward annual dividend yield is 7.47%.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, The RMR Group’s stock is considered to be overbought (>=80).
Yearly Top and Bottom Value
The RMR Group’s stock is valued at $24.13 at 17:15 EST, way under its 52-week high of $28.82 and way higher than its 52-week low of $20.79.
Revenue Growth
Year-on-year quarterly revenue growth declined by 6.3%, now sitting on 233.04M for the twelve trailing months.
More news about The RMR Group.
4. CHS (CHSCN) – Dividend Yield: 7.03%
CHS’s last close was $25.24, 6.17% under its 52-week high of $26.90. Intraday change was 0.2%.
CHS Inc., an integrated agricultural company, engages in the provision of grains, foods, and energy resources to businesses and consumers worldwide. The company operates through three segments: Energy, Ag, and Nitrogen Production. It is involved in the operation of petroleum refineries and pipelines; supply, marketing, and distribution of refined fuels, including gasoline, diesel fuel, and other energy products; blending, sale, and distribution of lubricants; and the supply of propane, asphalt, and other natural gas liquids. The company also processes and sells crude oil into refined petroleum products under the Cenex brand name to member cooperatives and other independent retailers through a network of approximately 1,500 sites; and provides transportation services. In addition, it processes and markets grains and oilseeds; and offers seeds, crop nutrients, crop protection products, animal feed, animal health products, and refined and renewable fuels, as well as refined oils, meal, soy flour, and processed sunflower products. Further, the company produces and sells nitrogen-based products, including methanol, UAN and urea, and related products; and offers cooperatives with various loans that meet commercial agriculture needs and loans to individual producers, as well as consulting and commodity risk management services primarily in the grains, oilseeds, fertilizer, livestock, dairy, and energy markets. Additionally, it produces and distributes edible oil-based products. CHS Inc. was founded in 1931 and is headquartered in Inver Grove Heights, Minnesota.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 14.75%.
More news about CHS.
5. Sonic Automotive (SAH) – Dividend Yield: 2.35%
Sonic Automotive’s last close was $51.12, 15.14% under its 52-week high of $60.24. Intraday change was 0.43%.
Sonic Automotive, Inc. operates as an automotive retailer in the United States. It operates in two segments, Franchised Dealerships and EchoPark. The Franchised Dealerships segment is involved in the sale of new and used cars and light trucks, and replacement parts; provision of vehicle maintenance, manufacturer warranty repair, and paint and collision repair services; and arrangement of extended warranties, service contracts, financing, insurance, and other aftermarket products for its guests. The EchoPark segment sells used cars and light trucks; and arranges finance and insurance product sales for its guests in pre-owned vehicle specialty retail locations. Sonic Automotive, Inc. was incorporated in 1997 and is based in Charlotte, North Carolina.
Earnings Per Share
As for profitability, Sonic Automotive has a trailing twelve months EPS of $4.97.
PE Ratio
Sonic Automotive has a trailing twelve months price to earnings ratio of 10.29. Meaning, the purchaser of the share is investing $10.29 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 19.94%.
More news about Sonic Automotive.
6. Abbott Laboratories (ABT) – Dividend Yield: 2.08%
Abbott Laboratories’s last close was $104.94, 13.73% below its 52-week high of $121.64. Intraday change was -1.61%.
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also offers laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for laboratories. In addition, the company provides pediatric and adult nutritional products; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.
Earnings Per Share
As for profitability, Abbott Laboratories has a trailing twelve months EPS of $3.27.
PE Ratio
Abbott Laboratories has a trailing twelve months price to earnings ratio of 33.37. Meaning, the purchaser of the share is investing $33.37 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 14.76%.
Volume
Today’s last reported volume for Abbott Laboratories is 3130700 which is 45.58% below its average volume of 5753350.
Revenue Growth
Year-on-year quarterly revenue growth grew by 2.2%, now sitting on 40.33B for the twelve trailing months.
Volatility
Abbott Laboratories’s last week, last month’s, and last quarter’s current intraday variation average was a positive 0.08%, a negative 0.29%, and a positive 0.86%.
Abbott Laboratories’s highest amplitude of average volatility was 0.26% (last week), 0.73% (last month), and 0.86% (last quarter).
Sales Growth
Abbott Laboratories’s sales growth for the current quarter is 6.9%.
More news about Abbott Laboratories.
